Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER) A Phase I Safety Clinical Trial Conference

Glassberg, Marilyn K, Minkiewicz, Julia, Toonkel, Rebecca L et al. (2017). Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER) A Phase I Safety Clinical Trial . CHEST, 151(5), 971-981. 10.1016/j.chest.2016.10.061

Open Access Industry Collaboration

cited authors

  • Glassberg, Marilyn K; Minkiewicz, Julia; Toonkel, Rebecca L; Simonet, Emmanuelle S; Rubio, Gustavo A; DiFede, Darcy; Shafazand, Shirin; Khan, Aisha; Pujol, Marietsy V; LaRussa, Vincent F; Lancaster, Lisa H; Rosen, Glenn D; Fishman, Joel; Mageto, Yolanda N; Mendizabal, Adam; Hare, Joshua M

sustainable development goals

authors

date/time interval

  • May 13, 2016 -

publication date

  • May 1, 2017

webpage

published in

keywords

  • BONE-MARROW
  • Critical Care Medicine
  • DOUBLE-BLIND
  • General & Internal Medicine
  • INTERSTITIAL PNEUMONIA
  • ISCHEMIC CARDIOMYOPATHY
  • Life Sciences & Biomedicine
  • MARROW PROGENITOR CELLS
  • MYOCARDIAL-INFARCTION
  • RANDOMIZED-TRIAL
  • RAT MODEL
  • Respiratory System
  • STROMAL CELLS
  • Science & Technology
  • TRANSENDOCARDIAL INJECTION
  • bone marrow
  • idiopathic pulmonary fibrosis
  • mesenchymal stem cells
  • safety trial

Location

  • San Francisco, CA

Digital Object Identifier (DOI)

Conference

  • International Conference of the American-Thoracic-Society (ATS)

publisher

  • ELSEVIER SCIENCE BV

start page

  • 971

end page

  • 981

volume

  • 151

issue

  • 5